What does Pillar Biosciences do?
Pillar Biosciences is a decision medicine company based in Natik, MA that leverages next-generation sequencing technology to optimize the selection of precision therapies for cancer patients. Its platform integrates proprietary SLIMamp and PiVAT technologies to facilitate NGS testing that localizes processes, reduces diagnostic costs, and improves access to complex testing.
How much did they raise?
The company raised $34.5M in a Series A funding round, with lead investments from Illumina and Soleus Capital, alongside contributions from existing investors, to support its commercial expansion.
What are their plans for the money?
The funds will be used to expand its commercial activities, enhance headcount and infrastructure, and support biopharma partnerships to drive further adoption of its distributable clinical testing kits. This expansion is poised to improve efficiency and broaden the impact of decision medicine.
What have they achieved so far?
Pillar Biosciences has already made significant progress by launching more than 20 NGS testing kits available in IVD or RUO formats, with several additional panels in development, cementing its role in advancing precision diagnostics.
